Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148642 · ClinicalTrials.gov registry record · Phase 3
Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)
A Phase 3 study, sponsored by C. R. Bard.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,003
- Enrollment target
NCT00148642 is a Phase 3 study that has completed, run by C. R. Bard. The registered enrollment target is 2,003 participants.
The verdict
NCT00148642, a Phase 3 study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,003 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the use of a silver-coated endotracheal tube (ETT) can reduce the incidence and/or delay the time of onset of VAP when compared to a non silver-coated ETT in patients who have been mechanically ventilated for \>= 24 hours.
Interventions
- DEVICE silver salts coated endotracheal tube
- DEVICE uncoated endotracheal tube
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,003 participants |
| Start Date | 2002-11 |
| Est. Completion | 2006-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00148642
The ClinicalTrials.gov registry entry for NCT00148642 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,003 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which silver salts coated endotracheal tube is the first listed.
NCT00148642 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00148642 about?
NCT00148642 is a clinical study titled "Silver-Coated Endotracheal Tube to Reduce Ventilator Associated Pneumonia (VAP)". The purpose of this study is to determine if the use of a silver-coated endotracheal tube (ETT) can reduce the incidence and/or delay the time of onset of VAP when compared to a non silver-coated ETT in patients who have been mechanically ventilated for \>= 24 hours.
What is the current status of trial NCT00148642?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,003 participants. The study started on 2002-11. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00148642?
The interventions under investigation include: silver salts coated endotracheal tube (DEVICE), uncoated endotracheal tube (DEVICE).
Who is sponsoring clinical trial NCT00148642?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.